{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:38:44Z","timestamp":1792589924923,"version":"4.5.0"},"reference-count":20,"publisher":"MyJove Corporation","issue":"231","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/71193","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:02:32Z","timestamp":1779836552000},"source":"Crossref","is-referenced-by-count":0,"title":["A Single Intravenous Dose of Indole-producing Attenuated <em>Brucella<\/em> in NOD Mice: Assessment of Type 1 Diabetes Onset and Islet Immune Remodeling"],"prefix":"10.3791","author":[{"given":"Kaylee","family":"Delgado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie G.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"de Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"eadn2404","DOI":"10.1126\/scitranslmed.adn2404","type":"journal-article","article-title":"A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes","volume":"16","author":"Bender","year":"2024","unstructured":"Bender C, et al. A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes. Sci Transl Med. 2024;16:eadn2404.","journal-title":"Sci Transl Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"eabn1716","DOI":"10.1126\/scitranslmed.abn1716","type":"journal-article","article-title":"Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models","volume":"14","author":"Yang","year":"2022","unstructured":"Yang SJ, et al. Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models. Sci Transl Med. 2022;14:eabn1716.","journal-title":"Sci Transl Med"},{"key":"ref3","volume-title":"NOD\/ShiLtJ (001976) datasheet","year":"2026","unstructured":"The Jackson Laboratory. NOD\/ShiLtJ (001976) datasheet. https:\/\/www.jax.org\/strain\/001976 (2026)."},{"issue":"9","key":"ref4","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.immuni.2024.07.016","type":"journal-article","article-title":"Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics","volume":"57","author":"Raeber","year":"2024","unstructured":"Raeber ME, et al. Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and tissue-homing characteristics. Immunity. 2024;57(9):2232-50.e10.","journal-title":"Immunity"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"e173107","DOI":"10.1172\/JCI173107","type":"journal-article","article-title":"A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models","volume":"134","author":"Efe","year":"2024","unstructured":"Efe O, et al. A humanized IL-2 mutein expands Tregs and prolongs transplant survival in preclinical models. J Clin Invest. 2024;134(5):e173107.","journal-title":"J Clin Invest"},{"issue":"7","key":"ref6","doi-asserted-by":"crossref","first-page":"e126471","DOI":"10.1172\/jci.insight.126471","type":"journal-article","article-title":"Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes","volume":"4","author":"Haque","year":"2019","unstructured":"Haque M, et al. Stem cell-derived tissue-associated regulatory T cells suppress the activity of pathogenic cells in autoimmune diabetes. JCI Insight. 2019;4(7):e126471.","journal-title":"JCI Insight"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.cmet.2020.10.022","type":"journal-article","article-title":"Protein prenylation drives discrete signaling programs for the differentiation and maintenance of effector Treg cells","volume":"32","author":"Su","year":"2020","unstructured":"Su W, et al. Protein prenylation drives discrete signaling programs for the differentiation and maintenance of effector Treg cells. Cell Metab. 2020;32(6):996-1011.e17.","journal-title":"Cell Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"114624","DOI":"10.1016\/j.intimp.2025.114624","type":"journal-article","article-title":"Exploiting regulatory T cells (Tregs): cutting-edge therapy for autoimmune diseases","volume":"155","author":"Hassan","year":"2025","unstructured":"Hassan M, Elzallat M, Mohammed DM, Balata M, El-Maadawy WH. Exploiting regulatory T cells (Tregs): cutting-edge therapy for autoimmune diseases. Int Immunopharmacol. 2025;155:114624.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41590-024-02062-x","type":"journal-article","article-title":"Differential roles of human CD4+ and CD8+ regulatory T cells in controlling self-reactive immune responses","volume":"26","author":"Chen","year":"2025","unstructured":"Chen X, et al. Differential roles of human CD4+ and CD8+ regulatory T cells in controlling self-reactive immune responses. Nat Immunol. 2025;26(2):230-9.","journal-title":"Nat Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"112724","DOI":"10.1016\/j.intimp.2024.112724","type":"journal-article","article-title":"Regulatory T cell-based therapy in type 1 diabetes: latest breakthroughs and evidence","volume":"140","author":"Huang","year":"2024","unstructured":"Huang Q, Zhu J. Regulatory T cell-based therapy in type 1 diabetes: latest breakthroughs and evidence. Int Immunopharmacol. 2024;140:112724.","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"e202451722","DOI":"10.1002\/eji.202451722","type":"journal-article","article-title":"Advances in regulatory cell therapy for type 1 diabetes: emerging strategies and future directions","volume":"55","author":"Passerini","year":"2025","unstructured":"Passerini L, Forlani A, Gregori S. Advances in regulatory cell therapy for type 1 diabetes: emerging strategies and future directions. Eur J Immunol. 2025;55(5):e202451722.","journal-title":"Eur J Immunol"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4049\/jimmunol.1501727","type":"journal-article","article-title":"Dietary indoles suppress delayed-type hypersensitivity by inducing a switch from proinflammatory Th17 cells to anti-inflammatory regulatory T cells through regulation of microRNA","volume":"196","author":"Singh","year":"2016","unstructured":"Singh NP, et al. Dietary indoles suppress delayed-type hypersensitivity by inducing a switch from proinflammatory Th17 cells to anti-inflammatory regulatory T cells through regulation of microRNA. J Immunol. 2016;196(3):1108-22.","journal-title":"J Immunol"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.celrep.2018.03.109","type":"journal-article","article-title":"Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages","volume":"23","author":"Krishnan","year":"2018","unstructured":"Krishnan S, et al. Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages. Cell Rep. 2018;23(4):1099-1111.","journal-title":"Cell Rep"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"2143222","DOI":"10.1080\/19490976.2022.2143222","type":"journal-article","article-title":"A metabolically engineered bacterium controls autoimmunity and inflammation by remodeling the pro-inflammatory microenvironment","volume":"14","author":"Das","year":"2022","unstructured":"Das JK, et al. A metabolically engineered bacterium controls autoimmunity and inflammation by remodeling the pro-inflammatory microenvironment. Gut Microbes. 2022;14(1):2143222.","journal-title":"Gut Microbes"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"100198","DOI":"10.1016\/j.jtauto.2023.100198","type":"journal-article","article-title":"Engineering live attenuated vaccines: old dogs learning new tricks","volume":"6","author":"Plocica","year":"2023","unstructured":"Plocica J, et al. Engineering live attenuated vaccines: old dogs learning new tricks. J Transl Autoimmun. 2023;6:100198.","journal-title":"J Transl Autoimmun"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/d41586-020-00197-z","type":"journal-article","article-title":"Could a bacteria-stuffed pill cure autoimmune diseases?","volume":"577","author":"Bender","year":"2020","unstructured":"Bender E. Could a bacteria-stuffed pill cure autoimmune diseases? Nature. 2020;577:S12-3.","journal-title":"Nature"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1631995","DOI":"10.3389\/fimmu.2025.1631995","type":"journal-article","article-title":"Editorial: next generation therapeutic modality to cure autoimmune diseases","volume":"16","author":"Chen","year":"2025","unstructured":"Chen G, Wang C, Wan Q, Dong F, Radstake T. Editorial: next generation therapeutic modality to cure autoimmune diseases. Front Immunol. 2025;16:1631995.","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"100320","DOI":"10.37349\/ei.2025.1003202","type":"journal-article","article-title":"Exploring immunotherapeutic strategies for bacterial and viral diseases","volume":"5","author":"Adedokun","year":"2025","unstructured":"Adedokun AI, et al. Exploring immunotherapeutic strategies for bacterial and viral diseases. Explor Immunol. 2025;5:100320.","journal-title":"Explor Immunol"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","type":"journal-article","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","unstructured":"Bankhead P, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878.","journal-title":"Sci Rep"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","type":"journal-article","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","unstructured":"Satija R, Farrell JA, Gennert D, Schier AF, Regev A. Spatial reconstruction of single-cell gene expression data. Nat Biotechnol. 2015;33(5):495-502.","journal-title":"Nat Biotechnol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jove.com\/t\/71193\/a-single-intravenous-dose-indole-producing-attenuated-brucella-nod","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:42:02Z","timestamp":1792586522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/71193\/a-single-intravenous-dose-indole-producing-attenuated-brucella-nod"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":20,"journal-issue":{"issue":"231","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/71193","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]}}}